Net Income (Quarterly) Chart

View Net Income (Quarterly) for ADGM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -6.717M
March 31, 2026 -6.995M
December 31, 2025 -3.306M
September 30, 2025 -10.12M
June 30, 2025 -3.947M
March 31, 2025 -7.713M
December 31, 2024 -57.37M
September 30, 2024 -4.629M
June 30, 2024 -5.025M
March 31, 2024 -8.018M
December 31, 2023 -2.22M
Date Value
September 30, 2023 -10.76M
June 30, 2023 -7.932M
March 31, 2023 -9.276M
December 31, 2022 1.181M
September 30, 2022 0.5648M
June 30, 2022 -0.196M
March 31, 2022 -0.2112M
December 31, 2021 -1.096M
September 30, 2021 -5.093M
June 30, 2021 -0.1624M
March 31, 2021 -0.2103M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 928.00M
AngioDynamics, Inc. -11.40M
Alphatec Holdings, Inc. -25.78M
AtriCure, Inc. 8.955M
Baxter International, Inc. 135.00M

Net Income (Quarterly) Related Metrics